SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'MA4'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GHM_A_CEDA1_1 (BETA-LACTAMASE) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 7 / 12 | SER A 70LYS A 73SER A 130ASN A 132LYS A 234GLY A 236ARG A 244 | EPE A 400 (-3.7A)NoneEPE A 400 (-2.5A)NoneEPE A 400 (-3.1A)EPE A 400 (-3.1A)MA4 A 310 ( 3.8A) | 0.66A | 1ghmA-1n9bA:32.4 | 1ghmA-1n9bA:29.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I2W_A_CFXA1300_2 (BETA-LACTAMASE) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 4 / 5 | TYR A 105LEU A 169THR A 235ARG A 244 | EPE A 400 (-3.6A)NoneEPE A 400 (-3.8A)MA4 A 310 ( 3.8A) | 0.39A | 1i2wA-1n9bA:34.6 | 1i2wA-1n9bA:36.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I2W_B_CFXB2300_1 (BETA-LACTAMASE) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 8 / 12 | SER A 70LYS A 73SER A 130ASN A 132GLU A 166GLY A 236ALA A 237ARG A 244 | EPE A 400 (-3.7A)NoneEPE A 400 (-2.5A)NoneNoneEPE A 400 (-3.1A)EPE A 400 (-4.0A)MA4 A 310 ( 3.8A) | 0.66A | 1i2wB-1n9bA:34.8 | 1i2wB-1n9bA:36.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MZE_A_CFXA364_1 (D-ALANYL-D-ALANINECARBOXYPEPTIDASEDACA) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 6 / 12 | SER A 70LYS A 73ASN A 132THR A 235GLY A 236ARG A 244 | EPE A 400 (-3.7A)NoneNoneEPE A 400 (-3.8A)EPE A 400 (-3.1A)MA4 A 310 ( 3.8A) | 1.15A | 3mzeA-1n9bA:21.6 | 3mzeA-1n9bA:22.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SH8_A_CEDA1_1 (BETA-LACTAMASE) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 9 / 12 | SER A 70TYR A 105SER A 130ASN A 132LYS A 234THR A 235GLY A 236ALA A 237ARG A 244 | EPE A 400 (-3.7A)EPE A 400 (-3.6A)EPE A 400 (-2.5A)NoneEPE A 400 (-3.1A)EPE A 400 (-3.8A)EPE A 400 (-3.1A)EPE A 400 (-4.0A)MA4 A 310 ( 3.8A) | 0.68A | 3sh8A-1n9bA:33.3 | 3sh8A-1n9bA:37.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SH8_B_CEDB1_1 (BETA-LACTAMASE) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 7 / 12 | SER A 70LYS A 73ASN A 132LYS A 234GLY A 236ALA A 237ARG A 244 | EPE A 400 (-3.7A)NoneNoneEPE A 400 (-3.1A)EPE A 400 (-3.1A)EPE A 400 (-4.0A)MA4 A 310 ( 3.8A) | 0.62A | 3sh8B-1n9bA:33.2 | 3sh8B-1n9bA:37.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SH8_B_CEDB1_1 (BETA-LACTAMASE) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 7 / 12 | SER A 70SER A 130ASN A 132LYS A 234GLY A 236ALA A 237ARG A 244 | EPE A 400 (-3.7A)EPE A 400 (-2.5A)NoneEPE A 400 (-3.1A)EPE A 400 (-3.1A)EPE A 400 (-4.0A)MA4 A 310 ( 3.8A) | 0.70A | 3sh8B-1n9bA:33.2 | 3sh8B-1n9bA:37.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ACB_B_DXCB1473_0 (TRANSLATIONELONGATION FACTORSELB) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 4 / 8 | ILE A 282GLY A 283SER A 271GLN A 277 | NoneMA4 A 300 ( 3.9A)NoneNone | 0.88A | 4acbB-1n9bA:undetectable4acbC-1n9bA:undetectable | 4acbB-1n9bA:20.784acbC-1n9bA:20.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 9 / 10 | TYR A 105SER A 130ASN A 132VAL A 216LYS A 234THR A 235GLY A 236ALA A 237ARG A 244 | EPE A 400 (-3.6A)EPE A 400 (-2.5A)NoneEPE A 400 (-4.6A)EPE A 400 (-3.1A)EPE A 400 (-3.8A)EPE A 400 (-3.1A)EPE A 400 (-4.0A)MA4 A 310 ( 3.8A) | 0.41A | 4fh2A-1n9bA:48.4 | 4fh2A-1n9bA:99.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9K_A_CEDA301_1 (BETA-LACTAMASE) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 10 / 12 | SER A 70TYR A 105SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236ALA A 237ARG A 244 | EPE A 400 (-3.7A)EPE A 400 (-3.6A)EPE A 400 (-2.5A)NoneNoneEPE A 400 (-3.1A)EPE A 400 (-3.8A)EPE A 400 (-3.1A)EPE A 400 (-4.0A)MA4 A 310 ( 3.8A) | 0.70A | 4n9kA-1n9bA:34.9 | 4n9kA-1n9bA:37.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9K_B_CEDB301_1 (BETA-LACTAMASE) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 9 / 12 | SER A 70SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236ALA A 237ARG A 244 | EPE A 400 (-3.7A)EPE A 400 (-2.5A)NoneNoneEPE A 400 (-3.1A)EPE A 400 (-3.8A)EPE A 400 (-3.1A)EPE A 400 (-4.0A)MA4 A 310 ( 3.8A) | 0.69A | 4n9kB-1n9bA:34.8 | 4n9kB-1n9bA:37.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OQR_A_2UOA502_1 (CYP105AS1) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 5 / 9 | PRO A 183VAL A 44ILE A 260VAL A 247ALA A 248 | NoneNoneNoneNoneMA4 A 300 (-3.4A) | 1.16A | 4oqrA-1n9bA:undetectable | 4oqrA-1n9bA:21.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHY_A_CEDA301_1 (BETA-LACTAMASE) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 8 / 12 | SER A 70SER A 130ASN A 132ASN A 170LYS A 234GLY A 236ALA A 237ARG A 244 | EPE A 400 (-3.7A)EPE A 400 (-2.5A)NoneNoneEPE A 400 (-3.1A)EPE A 400 (-3.1A)EPE A 400 (-4.0A)MA4 A 310 ( 3.8A) | 0.75A | 5ghyA-1n9bA:34.6 | 5ghyA-1n9bA:37.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHY_A_CEDA301_1 (BETA-LACTAMASE) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 6 / 12 | SER A 70TYR A 105ASN A 132ASN A 170GLY A 236ARG A 244 | EPE A 400 (-3.7A)EPE A 400 (-3.6A)NoneNoneEPE A 400 (-3.1A)MA4 A 310 ( 3.8A) | 1.40A | 5ghyA-1n9bA:34.6 | 5ghyA-1n9bA:37.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHY_B_CEDB301_1 (BETA-LACTAMASE) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 8 / 12 | SER A 70SER A 130ASN A 132ASN A 170LYS A 234GLY A 236ALA A 237ARG A 244 | EPE A 400 (-3.7A)EPE A 400 (-2.5A)NoneNoneEPE A 400 (-3.1A)EPE A 400 (-3.1A)EPE A 400 (-4.0A)MA4 A 310 ( 3.8A) | 0.72A | 5ghyB-1n9bA:34.8 | 5ghyB-1n9bA:37.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHY_B_CEDB301_1 (BETA-LACTAMASE) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 6 / 12 | SER A 70TYR A 105ASN A 132ASN A 170GLY A 236ARG A 244 | EPE A 400 (-3.7A)EPE A 400 (-3.6A)NoneNoneEPE A 400 (-3.1A)MA4 A 310 ( 3.8A) | 1.34A | 5ghyB-1n9bA:34.8 | 5ghyB-1n9bA:37.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHZ_A_CEDA301_1 (BETA-LACTAMASE) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 10 / 11 | SER A 70TYR A 105SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236ALA A 237ARG A 244 | EPE A 400 (-3.7A)EPE A 400 (-3.6A)EPE A 400 (-2.5A)NoneNoneEPE A 400 (-3.1A)EPE A 400 (-3.8A)EPE A 400 (-3.1A)EPE A 400 (-4.0A)MA4 A 310 ( 3.8A) | 0.69A | 5ghzA-1n9bA:34.9 | 5ghzA-1n9bA:37.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHZ_B_CEDB301_1 (BETA-LACTAMASE) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 9 / 10 | SER A 70TYR A 105SER A 130ASN A 132ASN A 170LYS A 234THR A 235GLY A 236ARG A 244 | EPE A 400 (-3.7A)EPE A 400 (-3.6A)EPE A 400 (-2.5A)NoneNoneEPE A 400 (-3.1A)EPE A 400 (-3.8A)EPE A 400 (-3.1A)MA4 A 310 ( 3.8A) | 0.72A | 5ghzB-1n9bA:34.8 | 5ghzB-1n9bA:37.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KGP_A_GCSA407_1 (PREDICTEDACETYLTRANSFERASE) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 4 / 8 | ARG A 259GLU A 48PRO A 29GLY A 283 | NoneNoneNoneMA4 A 300 ( 3.9A) | 1.08A | 5kgpA-1n9bA:undetectable | 5kgpA-1n9bA:20.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KGP_B_GCSB405_1 (PREDICTEDACETYLTRANSFERASE) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 4 / 8 | ARG A 259GLU A 48PRO A 29GLY A 283 | NoneNoneNoneMA4 A 300 ( 3.9A) | 1.11A | 5kgpB-1n9bA:undetectable | 5kgpB-1n9bA:20.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YCP_A_BRLA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) | 3 / 3 | GLY A 283VAL A 44MET A 46 | MA4 A 300 ( 3.9A)NoneNone | 0.65A | 5ycpA-1n9bA:0.0 | 5ycpA-1n9bA:15.47 |